Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical significance on overall survival. Learn more on SMMT stock here.
Discover how GPIQ leverages tech-focused covered calls on top AI stocks for consistent income & NAV growth. Ideal for tech bulls seeking high returns. Read Full Article →
BitcoinWorldSwiss Franc Forecasts: UBS Unveils Alarming Revisions Amid SNB’s Bold MovesIn the dynamic world of finance, where every market move can send ripples across global portfolios, even traditional currency shifts can signal significant trends for cryptocurrency enthusiasts. Recently, a major player, UBS, delivered a notable update regarding the Swiss
If there's one word that sums up recent years in logistics, it's this: unpredictable.From pandemic disruptions to volatile consumer demand, supply chains have had to evolve rapidly. And now, with inflation lingering and interest rates tightening budgets, businesses are rethinking Read Full Article →
ClearSign files a $50M mixed securities shelf, aiming to raise funds for growth. Read Full Article →
Connect with us
